Keith Flaherty
Keith Flaherty
Keith Flaherty (pronunciation: keeth flah-er-tee) is a renowned oncologist and researcher known for his significant contributions to the field of cancer research, particularly in the area of melanoma.
Etymology
The name Keith is of Scottish origin and means "wood" or "forest". The surname Flaherty is of Irish origin and is derived from the Gaelic "Ó Flaithbheartaigh", which means "bright ruler".
Biography
Keith Flaherty is a Professor of Medicine at Harvard Medical School and the Director of Clinical Research at the Massachusetts General Hospital Cancer Center. He is also the founder of the Termeer Center for Targeted Therapies. His research primarily focuses on developing targeted therapies for melanoma, a type of skin cancer.
Related Terms
- Oncology: The branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
- Melanoma: A type of skin cancer that develops from the pigment-producing cells known as melanocytes.
- Targeted therapy: A type of cancer treatment that uses drugs or other substances to precisely identify and attack cancer cells.
- Clinical research: A branch of healthcare science that determines the safety and effectiveness of medications, devices, diagnostic products, and treatment regimens intended for human use.
External links
- Medical encyclopedia article on Keith Flaherty
- Wikipedia's article - Keith Flaherty
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski